These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32131399)

  • 1. Design, Synthesis, Computational, and Preclinical Evaluation of
    Søborg Pedersen K; Baun C; Michaelsen Nielsen K; Thisgaard H; Ingemann Jensen A; Zhuravlev F
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32131399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties.
    Garnuszek P; Karczmarczyk U; Maurin M; Sikora A; Zaborniak J; Pijarowska-Kruszyna J; Jaroń A; Wyczółkowska M; Wojdowska W; Pawlak D; Lipiński PFJ; Mikołajczak R
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
    Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
    Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.
    Chen Y; Pullambhatla M; Foss CA; Byun Y; Nimmagadda S; Senthamizhchelvan S; Sgouros G; Mease RC; Pomper MG
    Clin Cancer Res; 2011 Dec; 17(24):7645-53. PubMed ID: 22042970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Preclinical Evaluation of [
    Bailey JJ; Wuest M; Wagner M; Bhardwaj A; Wängler C; Wängler B; Valliant JF; Schirrmacher R; Wuest F
    J Med Chem; 2021 Nov; 64(21):15671-15689. PubMed ID: 34672630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.
    Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S
    Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
    Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
    J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer.
    Yao X; Zha Z; Ploessl K; Choi SR; Zhao R; Alexoff D; Zhu L; Kung HF
    Bioorg Med Chem; 2020 Mar; 28(5):115319. PubMed ID: 32001090
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Lee BS; Chu SY; Jung WJ; Jeong HJ; Lee K; Kim MH; Kim MH; Chi DY; Ahn H; Lee YJ; Lee KC; Lim SM
    Prostate; 2020 Dec; 80(16):1383-1393. PubMed ID: 32960990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pre-clinical evaluation of a new class of high-affinity
    Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and preliminary evaluation of an integrin α
    Lu X; Wu M; Wang S; Hai W; Li P
    Bioorg Med Chem; 2022 Jan; 54():116583. PubMed ID: 34952297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of
    Potemkin R; Strauch B; Kuwert T; Prante O; Maschauer S
    Mol Pharm; 2020 Mar; 17(3):933-943. PubMed ID: 32011889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a novel urea-based
    Zha Z; Ploessl K; Choi SR; Wu Z; Zhu L; Kung HF
    Nucl Med Biol; 2018 Apr; 59():36-47. PubMed ID: 29459281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Evaluation of
    Cardinale J; Schäfer M; Benešová M; Bauder-Wüst U; Leotta K; Eder M; Neels OC; Haberkorn U; Giesel FL; Kopka K
    J Nucl Med; 2017 Mar; 58(3):425-431. PubMed ID: 27789722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates.
    Lu G; Maresca KP; Hillier SM; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1557-63. PubMed ID: 23333070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel multifunctional
    Kwon YD; Lee JY; La MT; Lee SJ; Lee SH; Park JH; Kim HK
    Eur J Med Chem; 2020 Mar; 189():112099. PubMed ID: 32014792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.
    Baranski AC; Schäfer M; Bauder-Wüst U; Roscher M; Schmidt J; Stenau E; Simpfendörfer T; Teber D; Maier-Hein L; Hadaschik B; Haberkorn U; Eder M; Kopka K
    J Nucl Med; 2018 Apr; 59(4):639-645. PubMed ID: 29191856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and preclinical evaluation of an Al
    Huang Y; Li H; Ye S; Tang G; Liang Y; Hu K
    Eur J Med Chem; 2021 Oct; 221():113502. PubMed ID: 33965863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Imaging Contrast of
    Baranski AC; Schäfer M; Bauder-Wüst U; Wacker A; Schmidt J; Liolios C; Mier W; Haberkorn U; Eisenhut M; Kopka K; Eder M
    Bioconjug Chem; 2017 Sep; 28(9):2485-2492. PubMed ID: 28787147
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation of
    Wang Y; Shao G; Wu J; Cui C; Zang S; Qiu F; Jia R; Wang Z; Wang F
    Contrast Media Mol Imaging; 2018; 2018():8046541. PubMed ID: 29853810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.